Albert Bourla, Pfizer CEO (Gian Ehrenzeller/Keystone via AP Images)
December 15, 2020 07:36 AM EST
Coronavirus

Covid-19 roundup: US ne­go­ti­at­ing for more dos­es of Pfiz­er vac­cine; Brazil de­lays ef­fi­ca­cy read­out for Sino­vac vac­cine

Nicole DeFeudis

Editor

Af­ter al­leged­ly pass­ing up an of­fer to ac­quire more dos­es of Pfiz­er and BioN­Tech’s Covid-19 vac­cine last month, the US gov­ern­ment is in ne­go­ti­a­tions to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Fed­er­al ap­peals court says Te­va must delist Or­ange Book in­haler patents

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

A service from the Financial Times